(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-1.35%) $82.72
(6.40%) $2.05
(0.02%) $2 347.70
(-0.27%) $27.46
(4.13%) $960.20
(-0.22%) $0.933
(-0.36%) $10.99
(-0.55%) $0.796
(1.66%) $93.40
0.04% $ 136.20
@ $136.62
Ausgestellt: 29 Apr 2024 @ 15:30
Rendite: -0.30%
Vorheriges Signal: Apr 26 - 18:07
Vorheriges Signal:
Rendite: 0.79 %
Live Chart Being Loaded With Signals
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry...
Stats | |
---|---|
Tagesvolumen | 386 715 |
Durchschnittsvolumen | 512 482 |
Marktkapitalisierung | 7.21B |
EPS | $0 ( 2024-02-27 ) |
Nächstes Ertragsdatum | ( $0.710 ) 2024-05-07 |
Last Dividend | $1.000 ( 2012-11-23 ) |
Next Dividend | $0 ( N/A ) |
P/E | 90.20 |
ATR14 | $2.41 (1.77%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-01 | Tripodi Blair | Buy | 30 000 | Restricted Stock Units |
2024-03-01 | Tripodi Blair | Buy | 9 127 | Non-Qualified Stock Option (Right to Buy) |
2024-03-01 | Muhsin Bilal | Buy | 30 000 | Restricted Stock Units |
2024-02-28 | Muhsin Bilal | Buy | 2 010 | Common Stock |
2024-02-28 | Muhsin Bilal | Sell | 745 | Common Stock |
INSIDER POWER |
---|
77.94 |
Last 93 transactions |
Buy: 793 924 | Sell: 148 839 |
Volumen Korrelation
Masimo Corp Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Masimo Corp Korrelation - Währung/Rohstoff
Masimo Corp Finanzdaten
Annual | 2023 |
Umsatz: | $2.05B |
Bruttogewinn: | $1.00B (49.00 %) |
EPS: | $1.540 |
FY | 2023 |
Umsatz: | $2.05B |
Bruttogewinn: | $1.00B (49.00 %) |
EPS: | $1.540 |
FY | 2022 |
Umsatz: | $2.04B |
Bruttogewinn: | $1.06B (52.01 %) |
EPS: | $2.68 |
FY | 2021 |
Umsatz: | $1.24B |
Bruttogewinn: | $808.35M (65.23 %) |
EPS: | $4.16 |
Financial Reports:
No articles found.
Masimo Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $2.00 | 2010-03-09 |
Last Dividend | $1.000 | 2012-11-23 |
Next Dividend | $0 | N/A |
Payout Date | 2012-12-11 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $3.75 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.91 | -- |
Div. Sustainability Score | 9.50 | |
Div.Growth Potential Score | 1.722 | |
Div. Directional Score | 5.61 | -- |
Year | Amount | Yield |
---|---|---|
2010 | $2.75 | 9.24% |
2011 | $0 | 0.00% |
2012 | $1.000 | 5.31% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0398 | 1.500 | 9.20 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0268 | 1.200 | 9.11 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0618 | 1.500 | -0.425 | -0.637 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.18 | 0.800 | 4.08 | 3.26 | [1 - 3] |
quickRatioTTM | 1.041 | 0.800 | 8.58 | 6.87 | [0.8 - 2.5] |
cashRatioTTM | 0.294 | 1.500 | 9.48 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.304 | -1.500 | 4.94 | -7.40 | [0 - 0.6] |
interestCoverageTTM | 3.14 | 1.000 | 9.95 | 9.95 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.782 | 2.00 | 9.41 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.121 | 2.00 | 9.94 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.677 | -1.500 | 7.29 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.490 | 1.000 | 5.17 | 5.17 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0769 | 1.000 | -0.463 | -0.463 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.102 | 1.000 | -0.545 | -0.545 | [0.2 - 2] |
assetTurnoverTTM | 0.673 | 0.800 | 8.84 | 7.08 | [0.5 - 2] |
Total Score | 9.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 88.20 | 1.000 | 1.192 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0618 | 2.50 | -0.273 | -0.637 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.121 | 2.00 | 9.96 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.782 | 2.00 | 9.41 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.307 | 1.500 | -1.289 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0459 | 1.000 | -1.351 | 0 | [0.1 - 0.5] |
Total Score | 1.722 |
Masimo Corp
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.